tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
GYRE
Gyre Therapeutics
RESEARCH TOOLSreports
Want to see GYRE full AI Analyst Report?

Gyre Therapeutics (GYRE) Income Statement

827 Followers

Gyre Therapeutics Income Statement

Last quarter (Q1 2026), Gyre Therapeutics's total revenue was $22.52M, an increase of 2.09% from the same quarter last year. In Q1, Gyre Therapeutics's net income was $-8.62M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 116.59M$ 105.76M$ 113.45M$ 102.29M$ 7.34M
Gross Profit
$ 111.17M$ 101.87M$ 108.81M$ 97.50M$ -332.00K
Operating Expenses
$ 99.68M$ 85.71M$ 176.04M$ 88.29M$ 83.39M
Depreciation and Amortization
$ 2.52M$ 1.59M$ 1.11M$ 1.13M$ 290.00K
EBITDA
$ 14.01M$ 17.82M$ 20.33M$ 10.33M$ -87.64M
Operating Income
$ 11.49M$ 16.16M$ -67.23M$ 9.20M$ -83.73M
Other Income/Expenses
$ 2.94M$ 7.05M$ -9.73M$ 209.00K$ -4.21M
Pretax Income
$ 14.44M$ 23.22M$ -76.97M$ 9.41M$ -87.93M
Net Income
$ 5.03M$ 12.09M$ -92.93M$ 2.30M$ -87.93M
Per Share Metrics
Basic EPS
$ 0.06$ 0.14$ -1.41$ 0.03$ -2.87
Diluted EPS
$ 0.02$ 0.05$ -1.41$ 0.03$ -2.87
Weighted Average Shares Outstanding
 89.34M 85.09M 65.83M 76.74M 30.64M
Weighted Average Shares Outstanding (Diluted)
 103.18M 102.29M 65.83M 75.69M 30.64M
Currency in USD

Gyre Therapeutics Earnings and Revenue History